SCHEMBL25662304

SCHEMBL25662304

N[C@H](COC1CCCCC1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GRIK1 P39086 3/20 0.44
▸ SLC1A3 P43003 4/20 0.41
▸ SLC1A2 P43004 4/20 0.41
▸ SLC1A1 P43005 4/20 0.41
▸ GRIK2 Q13002 1/20 0.41
▸ GRIN2D O15399 5/20 0.38
▸ GRIN3B O60391 5/20 0.38
▸ GRIN1 Q05586 5/20 0.38
▸ GRIN2A Q12879 5/20 0.38
▸ GRIN2B Q13224 5/20 0.38
▸ GRIN2C Q14957 5/20 0.38
▸ GRIN3A Q8TCU5 5/20 0.38
▸ DPP7 Q9UHL4 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.37
▸ KIF11 P52732 1/20 0.37
▸ LNPEP Q9UIQ6 1/20 0.36
▸ PTGS1 P23219 1/20 0.35
▸ SLC7A11 Q9UPY5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL724270 1.00 GRIK1 (0.44) GRIK1SLC1A3SLC1A2SLC1A1GRIK2
SCHEMBL3447889 1.00 GRIK1 (0.44) GRIK1SLC1A3SLC1A2SLC1A1GRIK2
SCHEMBL25356877 0.98 GRIK1 (0.42) GRIK1SLC1A3SLC1A2SLC1A1GRIK2
SCHEMBL25356880 0.98 GRIK1 (0.42) GRIK1SLC1A3SLC1A2SLC1A1GRIK2
SCHEMBL25660424 0.94 SLC1A3 (0.40) GRIK1SLC1A3SLC1A2SLC1A1GRIK2
SCHEMBL25662192 0.94 SLC1A3 (0.40) GRIK1SLC1A3SLC1A2SLC1A1GRIK2
SCHEMBL29855065 0.94 SLC1A3 (0.40) GRIK1SLC1A3SLC1A2SLC1A1GRIK2
SCHEMBL29855094 0.90 PTGS1 (0.39) GRIK1SLC1A3SLC1A2SLC1A1GRIK2
SCHEMBL25355957 0.81 NPC1 (0.43) GRIK1SLC1A3SLC1A2SLC1A1GRIK2
SCHEMBL25355953 0.81 NPC1 (0.43) GRIK1SLC1A3SLC1A2SLC1A1GRIK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230158179-A1 RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF RAYZEBIO, INC. 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230158179-A1 RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF PAICS, LNPEP, DNPEP GRIK1 2914/4885SLC1A3 172/4885SLC1A2 236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback